End-of-life anticancer treatment - a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies.

Thea Otto MattssonAnton PottegårdTrine Lembrecht JørgensenAnders GreenMette Bliddal

Published in: Acta oncologica (Stockholm, Sweden) (2021)

We found a stable overall rate at 16% of patients receiving anticancer treatment within one month prior to death in this nationwide sample of cancer deaths. Further research is needed to assess whether this level of end-of-life treatment is justified or reflects inappropriate use.

Keyphrases

combination therapy
squamous cell carcinoma
photodynamic therapy
radiation therapy
young adults
papillary thyroid
drug delivery
replacement therapy
rectal cancer